|
Human Protein Atlas
tissue mrna expression data Tissue Mrna Expression Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tissue+mrna+expression+data/med_rxiv__64898__2026__03__28__26349616-62-2-8?v=Human+Protein+Atlas Average 86 stars, based on 1 article reviews
tissue mrna expression data - by Bioz Stars,
2026-08
86/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
mrna expression data of tgif2 in normal tissues ![]() Mrna Expression Data Of Tgif2 In Normal Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tissue+mrna+expression+data/pmc11020094-123-5-22?v=Human+Protein+Atlas Average 90 stars, based on 1 article reviews
mrna expression data of tgif2 in normal tissues - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
tissue-specific mrna expression data ![]() Tissue Specific Mrna Expression Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tissue+mrna+expression+data/pm37798380-336-9-15?v=Human+Protein+Atlas Average 90 stars, based on 1 article reviews
tissue-specific mrna expression data - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Pfizer Inc
unpublished cynomolgus monkey liver tissue mrna expression profiling data ![]() Unpublished Cynomolgus Monkey Liver Tissue Mrna Expression Profiling Data, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tissue+mrna+expression+data/pm31879282-249-17-6?v=Pfizer+Inc Average 90 stars, based on 1 article reviews
unpublished cynomolgus monkey liver tissue mrna expression profiling data - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
mrna expression data for 37 different normal tissues ![]() Mrna Expression Data For 37 Different Normal Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tissue+mrna+expression+data/pmc07904710-43-10-17?v=Human+Protein+Atlas Average 90 stars, based on 1 article reviews
mrna expression data for 37 different normal tissues - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
bulk mrna consensus tissue gene expression data ![]() Bulk Mrna Consensus Tissue Gene Expression Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tissue+mrna+expression+data/pmc07315890__NEJMoa2020283_appendix_1-188-0-18?v=Human+Protein+Atlas Average 90 stars, based on 1 article reviews
bulk mrna consensus tissue gene expression data - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Illumina Inc
tissue-specific mrna expression data ![]() Tissue Specific Mrna Expression Data, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tissue+mrna+expression+data/pmc04266588-60-7-18?v=Illumina+Inc Average 90 stars, based on 1 article reviews
tissue-specific mrna expression data - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: The expression level of TGIF2 in different human cancers and its relationship to glioma prognosis. (A) TGIF2 mRNA expression across various human organs and tissues based on consensus dataset in HPA database. (B) Comparison of TGIF2 expression between normal and tumor tissues across 33 cancers in TCGA and the GTEx database. (C) Subcellular localization of TGIF2 in SH-SY5Y cells from HPA datasets. (D) The volcano plot of DEGs in GSE14805. Red points represent upregulated, blue points represents downregulated genes. (E) ROC curve of TGIF2 and other established prognostic genes (IDH1, IDH2, EGFR, TP53, CDC6, CDC14B, CHD5) in glioma. (F–H) Survival curves for OS (F) , DSS (G) and PFI (H) in gliomas using TCGA database. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Article Snippet: The mRNA expression data of
Techniques: Expressing, Comparison
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Clinical characteristics of glioma patients.
Article Snippet: The mRNA expression data of
Techniques:
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Logistic analysis of the association between TGIF2 expression and clinical characteristics.
Article Snippet: The mRNA expression data of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Associations between TGIF2 expression and various clinicopathologic characteristics in glioma. (A) Age. (B) IDH status. (C) 1p/19q codeletion status. (D) Primary therapy outcome. (E) OS events. (F) DSS events. (G) PFI events. (H) WHO grade. (I) Histological type. (J) Gender. (K) Race. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant.
Article Snippet: The mRNA expression data of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Prognostic value of TGIF2 expression level in glioma. (A) TGIF2 expression distribution and survival status. (B) Time-dependent ROC curves for TGIF2 expression in glioma. (C) Forest plot of OS by multivariate Cox regression analysis in glioma from TCGA database. (D) The nomogram for predicting 1-, 3-, or 5-year OS rates in patients with glioma. (E) The calibration curves for the nomogram.
Article Snippet: The mRNA expression data of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Univariate and multivariate cox regression analyses of clinical characteristics associated with overall survival.
Article Snippet: The mRNA expression data of
Techniques:
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Correlations between TGIF2 expression level and OS in different clinicopathologic subgroups of glioma by Kaplan-Meier survival curve analysis. (A) Age ≤ 60. (B) Age > 60. (C) Gender: Male. (D) Gender: Female. (E) Race: White. (F) WHO grade: G3. (G) 1p/19q codeletion: non-codeletion. (H) Histological type: Astrocytoma. (I) Primary therapy outcome: PD.
Article Snippet: The mRNA expression data of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Functional enrichment analysis of DEGs between TGIF2 high and low expression groups. (A) The volcano plot of DEGs. Red represents upregulated, blue represents downregulated genes. (B) GO and KEGG pathway enrichment analysis of DEGs. (C–H) GSEA functional enrichment analysis.
Article Snippet: The mRNA expression data of
Techniques: Functional Assay, Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Correlations between TGIF2 expression and immune cell infiltration in glioma. (A–C) Comparison of StromalScore, ImmuneScore, and EstimateScore between TGIF2 high and low expression groups. (D, E) Comparison of immune cell enrichment scores in high and low TGIF2 expression groups. (F) The lollipop chart showing the correlations between the relative abundances of 24 immune cells and TGIF2 expression levels. (G–N) Scatterplots demonstrating the positive correlation of TGIF2 expression with Th2 cells, macrophages, eosinophils, and neutrophils, and the negative correlation with mast cells, NK CD56bright cells, pDC cells, and TFH cells. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant.
Article Snippet: The mRNA expression data of
Techniques: Expressing, Comparison
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Analysis of genes coexpressed with TGIF2 in glioma. (A) Heatmap showing the 30 genes in glioma that were 15 positively and 15 negatively related to TGIF2. (B) PPI network of top 50 protein-coding genes positively and negatively correlated with TGIF2. (C) The top 10 hub genes of the PPI network in (B) . (D) The expression levels of the top 10 hub genes in normal and glioma tissues in TCGA and GTEx database. ∗∗∗p < 0.001.
Article Snippet: The mRNA expression data of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Knockdown of TGIF2 inhibits glioma cell invasion, migration and EMT in vitro . (A) Bar graph demonstrating the efficiency of siRNA knockdown of TGIF2 mRNA in U251 cells by RT-qPCR. (B) Western blot assay showing that siRNA effectively knocked down TGIF2 protein, and siTGIF2 downregulated N-cadherin protein expression in U251 cells. (C) Transwell assay demonstrating changes in the number of cells invaded after knockdown of TGIF2. Scale bar, 500 μm. (D) Scratch wound-healing assays were utilized to compare the distance of cell migration between TGIF2-inhibited group and control group at 0h and 24h after scratching. Scale bar, 500 μm. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Article Snippet: The mRNA expression data of
Techniques: Knockdown, Migration, In Vitro, Quantitative RT-PCR, Western Blot, Expressing, Transwell Assay, Control
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Knockout of TGIF2 suppresses glioma cell invasion, migration and EMT. (A) The gRNA sequences designed targeting exon 2 of TGIF2. (B) The editing efficiency of gRNA33 and gRNA140 on TGIF2 was verified in 293T cells utilizing Sanger sequencing. (C) TGIF2-gRNA33 in the UCSC browser. (D) Western blot assay showing the knockout efficiency of TGIF2 protein. WT, Wild type; KO, Knockout. (E) Transwell assays showing changes in the number of cells invaded after knockout of TGIF2. Scale bar, 500 μm. (F) Scratch wound-healing assays were utilized to compare the distance of cell migration between TGIF2-knockout group and control group at 0h and 24h after scratching. Scale bar, 250 μm. ∗p < 0.05.
Article Snippet: The mRNA expression data of
Techniques: Knock-Out, Migration, Sequencing, Western Blot, Control